Pamela Esposito, Ph.D.
Chief Business Officer
Pamela Esposito serves as Chief Business Officer of Replimune. Pamela has held a variety of strategy, commercial and business development positions in small biotech companies over the past 15 years, playing lead roles in transformative deals for each company. Previously, she was Chief Business Officer at Ra Pharmaceuticals. As a member of Ra’s senior management team, Pamela played a leadership role in strategy, helping Ra transform from a discovery platform to a clinical stage company and raising approximately $58 million in a Series B mezzanine funding round. Prior to Ra, she was VP of Business Development at Biovex and led the negotiation of the acquisition of the company by Amgen. Pamela earned a Ph.D. in pharmacology from Tufts University School of Medicine and a B.A. from Dartmouth College.